Spruce Biosciences, Inc. (SPRB)
NASDAQ·Healthcare·Biotechnology
$48.27
-3.44%
Mkt Cap $36.05M
Analyst Ratings
No recent rating data.
Price Target (8 analysts)
$131.33
Range $104.00 – $150.00
Implied Upside
+172.1%
Consensus $131.33 vs current $48.27
NASDAQ·Healthcare·Biotechnology
$48.27
-3.44%
Mkt Cap $36.05M
No recent rating data.
Price Target (8 analysts)
$131.33
Range $104.00 – $150.00
+172.1%
Consensus $131.33 vs current $48.27